论文部分内容阅读
本文通过42例流行性出血热(EHF)早期患者的抗过敏疗法对比观察表明,对抗Ⅰ型变态反应的抗过敏疗法组较对照组有越期率高、尿蛋白消失早、BUN 上升水平低等优点(p<0.01)。
In this paper, 42 patients with early epidemic of hemorrhagic fever (EHF) in patients with early anti-allergy therapy comparative study showed that anti-allergic type I allergy treatment group than the control group have a high probability of overdiagnosis, early disappearance of urinary protein, low levels of BUN rise Advantages (p <0.01).